resveratrol has been researched along with Leukemia in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (46.15) | 29.6817 |
| 2010's | 12 (46.15) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| He, BS; Hu, R; Li, Y; Liu, ML; Ruan, XL; Wang, B; Wang, J; Yang, YH; Zhu, J | 1 |
| Kang, PY; Li, YJ; Li, YY; Shi, M; Wang, SH; Wang, WJ; Zhang, YY | 1 |
| Frazzi, R; Guardi, M | 1 |
| Park, H; Seo, Y; Song, J | 1 |
| Al-Attar, T; Madihally, SV | 1 |
| Chen, JP; Huang, XT; Huang, YX; Huang, Z; Li, X; Liu, YX; Ming, QL; Peng, ZR; Sun, YN; Wu, GX; Xie, ML; Xu, SN | 1 |
| Chen, L; Gao, XX; Liu, GJ; Meng, J; Song, JY; Wang, AH; Wang, ZJ | 1 |
| Aoki, I; Bakalova, R; Ivanova, D; Semkova, S; Zhelev, Z | 1 |
| Luis Espinoza, J; Nakao, S; Takami, A; Trung, LQ | 1 |
| Frazzi, R; Tigano, M | 1 |
| Cao, D; Fang, X; Hu, L; Li, L; Yang, H; Zhang, Z | 1 |
| Chen, P; Guo, W; Pan, B; Wang, B | 1 |
| Lee, SK; Sanderson, BJ; Zhang, W | 1 |
| Athar, M; Back, JH; Bickers, DR; Kim, AL; Kopelovich, L | 1 |
| Du, ZX; Gao, YY; Guan, Y; Li, C; Li, N; Liu, BQ; Niu, XF; Wang, HQ | 1 |
| Platanias, LC; Vakana, E | 1 |
| Chikkappa, G; Maheshwari, JG; Tsan, MF; White, JE | 1 |
| Belloc, F; Billiard, C; Dupouy, M; Ferry-Dumazet, H; Garnier, O; Kolb, JP; Mamani-Matsuda, M; Marit, G; Mossalayi, MD; Reiffers, J; Thiolat, D; Vercauteren, J | 1 |
| Choi, SW; Kang, JH; Lee, WJ; Park, YH; Yang, EK | 1 |
| Ahmad, KA; Clement, MV; Hanif, IM; Pervaiz, S | 1 |
| Bozzi, A; Brisdelli, F; Cifone, G; Cinque, B; Luzi, C | 1 |
| Baatout, S; Derradji, H; Jacquet, P; Mergeay, M | 1 |
| Mertens-Talcott, SU; Percival, SS | 1 |
| Bader, Y; Erker, T; Handler, N; Kozics, K; Ovesná, Z; Saiko, P; Szekeres, T | 1 |
| Bodo, J; Duraj, J; Rauko, P; Sedlak, J; Sulikova, M | 1 |
| Chapman, RA; Divine, G; Gao, X; Gautam, SC; Janakiraman, N; Xu, YX | 1 |
6 review(s) available for resveratrol and Leukemia
| Article | Year |
|---|---|
Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells.
Topics: Anticarcinogenic Agents; Humans; Leukemia; Lymphoma; Resveratrol; Stilbenes | 2017 |
Resveratrol: Review on its discovery, anti-leukemia effects and pharmacokinetics.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Drug Discovery; Humans; Leukemia; Resveratrol | 2019 |
The multiple mechanisms of cell death triggered by resveratrol in lymphoma and leukemia.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Humans; Leukemia; Lymphoma; Models, Biological; Resveratrol; Stilbenes | 2014 |
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Cathepsins; Cell Cycle; Cell Division; Female; Humans; Inflammation; Leukemia; Lymphoma; Male; Neoplasms; Prostatic Neoplasms; Resveratrol; Safety; Stilbenes; Transcription Factors | 2009 |
AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications.
Topics: AMP-Activated Protein Kinase Kinases; Genes, abl; Hematologic Neoplasms; Humans; Leukemia; Metformin; Phosphatidylinositol 3-Kinase; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases | 2011 |
Anti-leukemia effect of resveratrol.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Hematopoietic Stem Cells; Humans; Leukemia; Resveratrol; Stilbenes | 2002 |
20 other study(ies) available for resveratrol and Leukemia
| Article | Year |
|---|---|
An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening.
Topics: Clone Cells; Cloning, Molecular; Early Detection of Cancer; Humans; Imatinib Mesylate; Leukemia; Microfluidics; Resveratrol | 2022 |
[The Mechanism of Resveratrol on Acute T-Lymphocyte Leukemia through IL-7-Mediated JAK / STAT Signaling Pathway].
Topics: Animals; Female; Interleukin-7; Janus Kinases; Leukemia; Mice; Mice, Inbred C57BL; Resveratrol; RNA, Messenger; Signal Transduction; STAT Transcription Factors; T-Lymphocytes | 2022 |
Pinosylvin enhances leukemia cell death via down-regulation of AMPKα expression.
Topics: AMP-Activated Protein Kinases; Apoptosis; Autophagy; Caspase 3; Down-Regulation; Gene Expression Regulation, Leukemic; Humans; Leukemia; Resveratrol; Stilbenes; THP-1 Cells; U937 Cells | 2018 |
Influence of controlled release of resveratrol from electrospun fibers in combination with siRNA on leukemia cells.
Topics: Drug Carriers; Drug Liberation; Gelatin; Humans; K562 Cells; Leukemia; Nanofibers; Polyesters; Resveratrol; RNA, Small Interfering | 2018 |
Preliminary results indicate resveratrol affects proliferation and apoptosis of leukemia cells by regulating PTEN/PI3K/AKT pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; HL-60 Cells; Humans; Leukemia; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; PTEN Phosphohydrolase; Resveratrol; Signal Transduction | 2019 |
Resveratrol Modulates the Redox-status and Cytotoxicity of Anticancer Drugs by Sensitizing Leukemic Lymphocytes and Protecting Normal Lymphocytes.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Humans; Leukemia; Lymphocytes; Oxidation-Reduction; Protective Agents; Reactive Oxygen Species; Resveratrol | 2019 |
Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility.
Topics: Anticarcinogenic Agents; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; DNA-Binding Proteins; Flow Cytometry; Humans; Killer Cells, Natural; Leukemia; Ligands; NK Cell Lectin-Like Receptor Subfamily K; Protein Serine-Threonine Kinases; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stilbenes; Tumor Suppressor Proteins; Up-Regulation | 2013 |
[Enhanced sensitivity of leukemia cell line KG-1a to activated immune cell-mediated cytolysis after treated with resveratrol].
Topics: Cell Line, Tumor; Cell Proliferation; Humans; Leukemia; Leukocytes, Mononuclear; Male; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor, Member 10c; Resveratrol; Stilbenes; TNF-Related Apoptosis-Inducing Ligand | 2014 |
Resveratrol-4‑O-D‑(2'-galloyl)-glucopyranoside exerts an anticancer effect on leukemia cells via inducing apoptosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Flow Cytometry; Glucosides; Leukemia; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays | 2016 |
Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction.
Topics: Anticarcinogenic Agents; Apoptosis; B-Lymphocytes; Cell Cycle; Cell Division; Cell Line; HL-60 Cells; Humans; Leukemia; Micronucleus Tests; Resveratrol; Stilbenes | 2008 |
Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1.
Topics: Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Cytoprotection; Cytotoxins; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Enzyme Inhibitors; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression Regulation, Leukemic; Humans; K562 Cells; Leukemia; Proteasome Inhibitors; Resveratrol; Stilbenes; U937 Cells | 2011 |
Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells.
Topics: Apoptosis; Bone Marrow Cells; Cell Division; Humans; Leukemia; Resveratrol; Stilbenes | 2002 |
Resveratrol derivatives potently induce apoptosis in human promyelocytic leukemia cells.
Topics: Apoptosis; Aryl Hydrocarbon Hydroxylases; Cell Cycle; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme System; Flow Cytometry; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia; Resveratrol; RNA, Messenger; Stilbenes | 2003 |
Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Daunorubicin; HL-60 Cells; Humans; Hydrogen Peroxide; Leukemia; Mitochondria; NADPH Oxidases; Oxidation-Reduction; Resveratrol; Stilbenes; Superoxides; Vincristine | 2004 |
Differential sensitivity to resveratrol-induced apoptosis of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells.
Topics: Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspases; Cell Proliferation; Cell Survival; Cytochromes c; Enzyme Activation; Glutathione; Humans; K562 Cells; Leukemia; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2004 |
Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin-gallate, resveratrol and curcuma.
Topics: Annexin A5; Apoptosis; Catechin; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Curcuma; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Eosinophils; Flow Cytometry; Humans; Leukemia; Necrosis; Plant Extracts; Radiation Tolerance; Radiation, Ionizing; Resveratrol; Signal Transduction; Stilbenes; Time Factors; X-Rays | 2005 |
Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells.
Topics: Anticarcinogenic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Drug Synergism; Ellagic Acid; Humans; Leukemia; Quercetin; Resveratrol; Stilbenes | 2005 |
Antioxidant activity of resveratrol, piceatannol and 3,3',4,4',5,5'-hexahydroxy-trans-stilbene in three leukemia cell lines.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Cell Survival; DNA Damage; HL-60 Cells; Humans; Hydrogen Peroxide; K562 Cells; Leukemia; Mice; Oxidants; Protein-Tyrosine Kinases; Resveratrol; Ribonucleotide Reductases; Stilbenes | 2006 |
Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells.
Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Busulfan; Cell Cycle; Cell Line, Tumor; Cycloheximide; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gemcitabine; Humans; Leukemia; Paclitaxel; Resveratrol; Stilbenes | 2006 |
Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Flavonoids; In Vitro Techniques; Leukemia; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Phenols; Polymers; Polyphenols; Resveratrol; Stilbenes; Tumor Cells, Cultured; Vitis | 2002 |